Publications

1. Alessy SA, Morgan E, Al-Zahrani AS, Zahwe M, Fouad H, Bray F, et al. (2025). Burden of five major types of gastrointestinal cancer in the Eastern Mediterranean Region. BMJ Open Gastroenterol. 12(1). https://doi.org/10.1136/bmjgast-2024-001577 PMID: 39971587
2. Best AF, Filho AM, Rosenberg PS (2025). Forecasting cancer incidence and prevalence using age-period-cohort and survivorship models: a practical, flexible, and interpretable framework. Front Oncol. 15: 1484896. https://doi.org/10.3389/fonc.2025.1484896 PMID: 40224176
3. Brandariz J, Pérez-Ríos M, Ruano-Ravina A, Soerjomataram IF (2025). Reflections on the tobacco-free generation: methodological challenges and global implications. Lancet Public Health. 10(2): e83-e83.
4. Bray FI, Laversanne M, Colombet MF (2025). Stat Bite: National or subnational coverage of population-based cancer registries included in Cancer Incidence in Five Continents, Volume XII. Jnci-Journal of the National Cancer Institute. 117(2): 383-384. https://doi.org/10.1093/jnci/djae303
5. Dal Maso L, Vaccarella S, Franceschi S (2025). Trends in thyroid cancer incidence and overdiagnosis in the USA. Lancet Diabetes Endocrinol. 13(3): 167-169. https://doi.org/10.1016/S2213-8587(24)00343-7 PMID: 39922211
6. Daltveit DS, Morgan E, Colombet M, Steliarova-Foucher E, Bendahhou K, Marcos-Gragera R, et al. (2025). Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022. Leukemia. 39(2): 412-419. https://doi.org/10.1038/s41375-024-02452-y PMID: 39567675
7. de Heus E, Duijts SFA, van der Zwan JM, van Herpen CML, Merkx MAW, Rutherford MJ, et al. (2025). Measuring healthy life expectancy and determinants of poor perceived health: A population-based study among a subset of rare and common cancer survivors. Cancer Epidemiol. 94: 102706. https://doi.org/10.1016/j.canep.2024.102706 PMID: 39579642
8. de Vries E, Arias-Ortiz N, Pineros M (2025). Commentary to Oliveros et al., Cancer Epidemiol 2025;96:102784. Cancer Epidemiol. 96: 102813. https://doi.org/10.1016/j.canep.2025.102813 PMID: 40184951
9. Dee EC, Laversanne M, Bhoo-Pathy N, Ho FDV, Feliciano EJG, Eala MAB, et al. (2025). Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis. Lancet Oncol. 26(4): 516-528. https://doi.org/10.1016/S1470-2045(25)00017-8 PMID: 40024257
10. Fedoriw Y, Silva O, Znaor A, Macintyre E (2025). Global view of haematolymphoid tumor classifications and their application in low- and middle-income countries. Histopathology. 86(1): 6-16. https://doi.org/10.1111/his.15340 PMID: 39420576
11. Filho AM, Laversanne M, Ferlay J, Colombet M, Pineros M, Znaor A, et al. (2025). The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 156(7): 1336-1346. https://doi.org/10.1002/ijc.35278 PMID: 39688499
12. Filho AM, Znaor A, Sunguc C, Zahwe M, Marcos-Gragera R, Figueroa JD, et al. (2025). Cancers of the brain and central nervous system: global patterns and trends in incidence. J Neurooncol. 172(3): 567-578. https://doi.org/10.1007/s11060-025-04944-y PMID: 39883354
13. Hermansen M, Hjelmborg J, Thinggaard M, Znaor A, Skakkebaek NE, Lindahl-Jacobsen R (2025). Smoking and testicular cancer: A Danish nationwide cohort study. Cancer Epidemiol. 95: 102746. https://doi.org/10.1016/j.canep.2025.102746 PMID: 39813870
14. Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. (2025). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 31(4): 1154-1162. https://doi.org/10.1038/s41591-025-03502-3 PMID: 39994475
15. Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, et al. (2025). Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respir Med. 13(4): 348-363. https://doi.org/10.1016/S2213-2600(24)00428-4 PMID: 39914442
16. Pineros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, et al. (2025). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? Int J Cancer. 156(7): 1358-1368. https://doi.org/10.1002/ijc.35232 PMID: 39580808
17. Radhakrishnan V, Jothi A, Mary R, Veeraiah S, Sudhakar R, Selvam P, et al. (2025). Assessment of Barriers and Enablers for Implementing a Population-Based Childhood Cancer Registry in Chennai, India. Pediatr Blood Cancer. 72(3): e31500. https://doi.org/10.1002/pbc.31500 PMID: 39739444
18. Rey Brandariz J, Perez-Rios M, Ruano-Ravina A, Soerjomataram I (2025). Reflections on the tobacco-free generation: methodological challenges and global implications – Authors’ reply. Lancet Public Health. 10(2): e83. https://doi.org/10.1016/S2468-2667(25)00008-8 PMID: 39909695
19. Schafer EJ, Laversanne M, Sung H, Soerjomataram I, Briganti A, Dahut W, et al. (2025). Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. Eur Urol. 87(3): 302-313. https://doi.org/10.1016/j.eururo.2024.11.013 PMID: 39668103
20. Shah R, Battisti NML, Brain E, Gnangnon FHR, Kanesvaran R, Mohile S, et al. (2025). Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates. Cancer Epidemiol. 95: 102716. https://doi.org/10.1016/j.canep.2024.102716 PMID: 39603975
21. Shah R, Hanna NM, Loo CE, David M, Mafra A, Fink H, et al. (2025). The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis. Nat Cancer. 6(1): 194-204. https://doi.org/10.1038/s43018-024-00880-4 PMID: 39747650
22. Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, et al. (2025). Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 26(1): 51-63. https://doi.org/10.1016/S1470-2045(24)00600-4 PMID: 39674189
23. Zahwe M, Bendahhou K, Eser S, Mukherji D, Fouad H, Fadhil I, et al. (2025). Current and future burden of female breast cancer in the Middle East and North Africa region using estimates from GLOBOCAN 2022. Int J Cancer. 156(12): 2320-2329. https://doi.org/10.1002/ijc.35325 PMID: 39791948
24. Znaor A, Fouad H, Zahwe M, Eser S, Fadhil I, Soerjomataram I, et al. (2025). Cancer surveillance in the Eastern Mediterranean region: a 10-year International Agency for Research on Cancer-WHO Regional Office for the Eastern Mediterranean collaboration. Lancet Oncol. 26(3): e131-e139. https://doi.org/10.1016/S1470-2045(24)00624-7 PMID: 40049204
25. Abu Awwad D, Shafiq J, Delaney GP, Anacak Y, Bray F, Flores JA, et al. (2024). Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis. Lancet Oncol. 25(2): 225-234. https://doi.org/10.1016/S1470-2045(23)00619-8 PMID: 38301690
26. Alessy SA, Alqahtani SA, Vignat J, Abuhmaidan A, Basmi AEL, Al Lawati N, et al. (2024). The current and future cancer burden in the Gulf Cooperation Council (GCC) countries. Cancer Med. 13(17): e70141. https://doi.org/10.1002/cam4.70141 PMID: 39279725
27. Benitez Fuentes JD, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. (2024). Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis. JAMA Oncol. 10(1): 71-78. https://doi.org/10.1001/jamaoncol.2023.4837 PMID: 37943547
28. Benitez Fuentes JD, Morgan E, Soerjomataram I (2024). Clarification Regarding Breast Cancer Stage in France-Reply. JAMA Oncol. 10(6): 832-833. https://doi.org/10.1001/jamaoncol.2024.0671 PMID: 38662350
29. Bray F (2024). Cancer trends in the UK. BMJ. 384: q504. https://doi.org/10.1136/bmj.q504 PMID: 38479756
30. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3): 229-263. https://doi.org/10.3322/caac.21834 PMID: 38572751
31. Businge L, Hagenimana M, Motlhale M, Bardot A, Liu B, Anastos K, et al. (2024). Stage at diagnosis and survival by stage for the leading childhood cancers in Rwanda. Pediatr Blood Cancer. 71(7): e31020. https://doi.org/10.1002/pbc.31020 PMID: 38668553
32. Corredor C, Pineros M, Wiesner C, de Vries E (2024). Using administrative registries as a source for population-based cancer incidence and mortality. BMC Cancer. 24(1): 232. https://doi.org/10.1186/s12885-023-11754-w PMID: 38373947
33. de Paula Silva N, Colombet M, Moreno F, Erdmann F, Dolya A, Pineros M, et al. (2024). Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Rev Panam Salud Publica. 48: e11. https://doi.org/10.26633/RPSP.2024.11 PMID: 38410357
34. de Paula Silva N, Gini A, Dolya A, Colombet M, Soerjomataram I, Youlden D, et al. (2024). Prevalence of childhood cancer survivors in Europe: a scoping review. EJC Paediatr Oncol. 3. https://doi.org/10.1016/j.ejcped.2024.100155 PMID: 38915419
35. Fantin R, Sierra MS, Vaccarella S, Herrero R, Barboza-Solis C (2024). Social gradient and rural-urban disparities in cancer mortality in Costa Rica. Cancer Epidemiol. 91: 102604. https://doi.org/10.1016/j.canep.2024.102604 PMID: 38941875
36. Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, et al. (2024). Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiol. 89: 102525. https://doi.org/10.1016/j.canep.2024.102525 PMID: 38228040
37. Gizaw M, Parkin DM, Stoter O, Bukirwa P, Seife E, Chesumbai G, et al. (2024). Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study. Int J Cancer. 154(11): 1911-1919. https://doi.org/10.1002/ijc.34877 PMID: 38339849
38. Guimaraes Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F (2024). Ethnic disparities in cancer mortality in the capital and northeast of the State of Sao Paulo, Brazil 2001-17. Cancer Causes Control. 35(3): 523-529. https://doi.org/10.1007/s10552-023-01812-w PMID: 37917366
39. Hagenimana M, Motlhale M, Parkin DM, Businge L, Bardot A, Liu B, et al. (2024). Stage at diagnosis and survival among adult patients with cancer in Rwanda: A population-based study. Int J Cancer. 155(6): 988-995. https://doi.org/10.1002/ijc.34969 PMID: 38888375
40. Islami F, Marlow EC, Thomson B, McCullough ML, Rumgay H, Gapstur SM, et al. (2024). Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA Cancer J Clin. 74(5): 405-432. https://doi.org/10.3322/caac.21858 PMID: 38990124
41. James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 403(10437): 1683-1722. https://doi.org/10.1016/S0140-6736(24)00651-2 PMID: 38583453
42. Joko-Fru WY, Bardot A, Bukirwa P, Amidou S, N’da G, Woldetsadik E, et al. (2024). Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study. Lancet Glob Health. 12(6): e947-e959. https://doi.org/10.1016/S2214-109X(24)00130-X PMID: 38762297
43. Kenessey I, Parrag P, Dobozi M, Szatmari I, Weber A, Nagy P, et al. (2024). The epidemiology of lung cancer in Hungary based on the characteristics of patients diagnosed in 2018. Sci Rep. 14(1): 20064. https://doi.org/10.1038/s41598-024-70143-w PMID: 39209889
44. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al. (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4): eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID: 38277453
45. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 154(2): 389-402. https://doi.org/10.1002/ijc.34710 PMID: 37694289
46. Li M, Dal Maso L, Pizzato M, Vaccarella S (2024). Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 12(11): 824-836. https://doi.org/10.1016/S2213-8587(24)00223-7 PMID: 39389067
47. Malagon T, Franco EL, Tejada R, Vaccarella S (2024). Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 21(7): 522-538. https://doi.org/10.1038/s41571-024-00904-z PMID: 38760499
48. Moen L, Liu B, Bukirwa P, Chingonzoh T, Chokunonga E, Finesse A, et al. (2024). Trends in the incidence of colorectal cancer in sub-Saharan Africa: A population-based registry study. Int J Cancer. 155(4): 675-682. https://doi.org/10.1002/ijc.34942 PMID: 38568397
49. Moreira DC, Znaor A, Santana VM, Dolya A, Fox Irwin L, Bhakta N, et al. (2024). Expanding the Global Capacity for Childhood Cancer Registration: The ChildGICR Masterclass. JCO Glob Oncol. 10: e2300334. https://doi.org/10.1200/GO.23.00334 PMID: 38905577
50. Morgan E, O’Neill C, Bardot A, Walsh P, Woods RR, Gonsalves L, et al. (2024). Collecting Long-Term Outcomes in Population-Based Cancer Registry Data: The Case of Breast Cancer Recurrence. JCO Glob Oncol. 10: e2400249. https://doi.org/10.1200/GO-24-00249 PMID: 39481072
51. Morgan E, O’Neill C, Shah R, Langselius O, Su Y, Frick C, et al. (2024). Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 26(1): 171. https://doi.org/10.1186/s13058-024-01881-y PMID: 39605105
52. Murthy SS, Trapani D, Cao B, Bray F, Murthy S, Kingham TP, et al. (2024). Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000-19: a retrospective, cross-sectional, population-based study. Lancet Oncol. 25(8): 969-978. https://doi.org/10.1016/S1470-2045(24)00274-2 PMID: 38964357
53. Poudel KK, Singh D, Sims DJ (2024). Gastric Cancer Survival and Its Predictors in Nepal. Asian Pac J Cancer Prev. 25(10): 3635-3642. https://doi.org/10.31557/APJCP.2024.25.10.3635 PMID: 39471031
54. Rahman MS, Rahman MM, Acharya K, Haruyama R, Shah R, Matsuda T, et al. (2024). Disparities and Determinants of Testing for Early Detection of Cervical Cancer among Nepalese Women: Evidence from a Population-Based Survey. Cancer Epidemiol Biomarkers Prev. 33(8): 1046-1056. https://doi.org/10.1158/1055-9965.EPI-24-0037 PMID: 38820125
55. Reid F, Adams T, Adel RS, Andrade CE, Bajwa A, Bambury IG, et al. (2024). The every woman study low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer. PLoS One. 19(5): e0298154. https://doi.org/10.1371/journal.pone.0298154 PMID: 38809901
56. Rey Brandariz J, Rumgay H, Ayo-Yusuf O, Edwards R, Islami F, Liu S, et al. (2024). Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. Lancet Public Health. 9(10): e745-e754. https://doi.org/10.1016/S2468-2667(24)00185-3 PMID: 39366730
57. Ritter J, de Braganca J, Auste C, Mendez A, Cohen PD, Fajardo AF, et al. (2024). Novel Framework of Financial Hardship in Childhood Cancer: Incorporating Stakeholder Perspectives. JCO Glob Oncol. 10: e2400093. https://doi.org/10.1200/GO.24.00093 PMID: 39208390
58. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25(11): 1413-1423. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID: 39393386
59. Shah R, Loo CE, Hanna NM, Hughes S, Mafra A, Fink H, et al. (2024). Global review of COVID-19 mitigation strategies and their impact on cancer service disruptions. J Cancer Policy. 41: 100486. https://doi.org/10.1016/j.jcpo.2024.100486 PMID: 38830535
60. Smith CDL, McMahon AD, Lyall DM, Goulart M, Inman GJ, Ross A, et al. (2024). Development and external validation of a head and neck cancer risk prediction model. Head Neck. 46(9): 2261-2273. https://doi.org/10.1002/hed.27834 PMID: 38850089
61. Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G, et al. (2024). Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies. Alcohol Clin Exp Res (Hoboken). 48(12): 2222-2241. https://doi.org/10.1111/acer.15493 PMID: 39581746
62. Steinberg J, Hughes S, Hui H, Allsop MJ, Egger S, David M, et al. (2024). Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. Int J Cancer. 154(8): 1394-1412. https://doi.org/10.1002/ijc.34798 PMID: 38083979
63. Stoer NC, Vangen S, Singh D, Fortner RT, Hofvind S, Ursin G, et al. (2024). Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway. Br J Cancer. 131(1): 126-137. https://doi.org/10.1038/s41416-024-02590-1 PMID: 38740969
64. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, et al. (2024). Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 15(1): 7835. https://doi.org/10.1038/s41467-024-51679-x PMID: 39244563
65. Trias-Llimos S, Renteria E, Rutigliano R, Aggarwal A, Moodley J, Unger-Saldana K, et al. (2024). Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019. J Natl Cancer Inst. 116(12): 1934-1941. https://doi.org/10.1093/jnci/djae191 PMID: 39141445
66. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. (2024). Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study. BMJ. 386: e077738. https://doi.org/10.1136/bmj-2023-077738 PMID: 39231588
67. Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, et al. (2024). Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 9(3): 229-237. https://doi.org/10.1016/S2468-1253(23)00366-7 PMID: 38185129
68. Weber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P, et al. (2024). Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 42(1): 237. https://doi.org/10.1007/s00345-024-04949-8 PMID: 38625417
69. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2024). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tob Control. 33(3): 295-301. https://doi.org/10.1136/tc-2022-057262 PMID: 36100264
70. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. Int J Cancer. 154(1): 28-40. https://doi.org/10.1002/ijc.34671 PMID: 37615573
71. Znaor A, Eser S, Bendahhou K, Shelpai W, Al Lawati N, A EL, et al. (2024). Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study. Int J Cancer. 155(1): 54-60. https://doi.org/10.1002/ijc.34895 PMID: 38456478
72. Ali M, Nusselder W, Weiderpass E, Corbex M, Bray F, Vaccarella S (2023). Inequities in cancer outcomes. Bulletin of the World Health Organization. 101(9): 550. https://doi.org/10.2471/BLT.23.290661 PMID:37663873
73. Banham D, Roder D, Thompson S, Williamson A, Bray F, Currow D (2023). The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales. Cancer Causes and Control. 34(10): 909-926. https://doi.org/10.1007/s10552-023-01727-6 PMID:37329444
74. Barchuk A, Tursun-Zade R, Nazarova E, Komarov Y, Tyurina E, Tumanova Y, et al. (2023). Completeness of regional cancer registry data in Northwest Russia 2008-2017. BMC Cancer. 23(1): 994. https://doi.org/10.1186/s12885-023-11492-z PMID:37853404
75. Bauer M, Vetter M, Stuckrath K, Yohannes M, Desalegn Z, Yalew T, et al. (2023). Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 11(6): 720-731. https://doi.org/10.1158/2326-6066.CIR-22-0795 PMID:37058582
76. Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. (2023). 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. European Urology. 84(2): 191-206. https://doi.org/10.1016/j.eururo.2023.04.021 PMID:37202314
77. Blanco-Lopez J, Iguacel I, Pisanu S, Almeida CCB, Steliarova-Foucher E, Sierens C, et al. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 20(7): 5428. https://doi.org/10.3390/ijerph20075428 PMID:37048042
78. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. International Journal of Cancer. 152(10): 2069-2080. https://doi.org/10.1002/ijc.34444 PMID:36694401
79. Cabasag CJ, Arnold M, Rutherford M, Ferlay J, Bardot A, Morgan E, et al. (2023). Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. International Journal of Cancer. 152(9): 1763-1777. https://doi.org/10.1002/ijc.34403 PMID:36533660
80. Chen JG, Chen HZ, Zhu J, Shen AG, Sun XY, Parkin DM (2023). Cancer survival: left truncation and comparison of results from hospital-based cancer registry and population-based cancer registry. Frontiers in Oncology. 13: 1173828. https://doi.org/10.3389/fonc.2023.1173828 PMID:37350938
81. De Camargo Cancela M, Monteiro Dos Santos JE, Lopes de Souza LB, Martins LFL, Bezerra de Souza DL, Barchuk A, et al. (2023). The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030. Cancer Epidemiology. 86: 102438. https://doi.org/10.1016/j.canep.2023.102438 PMID:37579673
82. Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Ferlay J, Bray F, et al. (2023). Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis. International Journal of Cancer. 152(3): 417-428. https://doi.org/10.1002/ijc.34269 PMID:36054026
83. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. (2023). Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 11(11): e1700-e1712. https://doi.org/10.1016/S2214-109X(23)00406-0 PMID:37774721
84. Ghasemi-Kebria F, Jafari-Delouie N, Semnani S, Fazel A, Etemadi A, Norouzi A, et al. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiology. 86: 102415. https://doi.org/10.1016/j.canep.2023.102415 PMID:37442047
85. Ghasemi-Kebria F, Semnani S, Fazel A, Etemadi A, Amiriani T, Naeimi-Tabiei M, et al. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. International Journal of Cancer. 153(1): 73-82. https://doi.org/10.1002/ijc.34518 PMID:36943026
86. Gini A, Colombet M, de Paula Silva N, Visser O, Youlden D, Soerjomataram I, et al. (2023). A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands. International Journal of Epidemiology. 52(6): 1898-1906. https://doi.org/10.1093/ije/dyad124 PMID:37738448
87. Ginsburg O, Vanderpuye V, Beddoe AM, Bhoo-Pathy N, Bray F, Caduff C, et al. (2023). Women, power, and cancer: a Lancet Commission. Lancet. 402(10417): 2113-2166. https://doi.org/10.1016/S0140-6736(23)01701-4 PMID:37774725
88. Gizaw M, Parkin DM, Stoter O, Korir A, Kamate B, Liu B, et al. (2023). Trends in the incidence of ovarian cancer in sub-Saharan Africa. International Journal of Cancer. 152(7): 1328-1336. https://doi.org/10.1002/ijc.34335 PMID:36274630
89. Guimaraes Ribeiro A, Ferlay J, Piñeros M, Dias de Oliveira Latorre MdR, Tavares Guerreiro Fregnani JH, Bray F (2023). Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001–17. Cancer Epidemiology. 85: 102403. https://doi.org/10.1016/j.canep.2023.102403 PMID:37390700
90. Hammerl L, Mezger NCS, Seraphin TP, Joko-Fru WY, Griesel M, Feuchtner J, et al. (2023). Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study. Journal of the National Comprehensive Cancer Network. 21(9): 924-933 e927. https://doi.org/10.6004/jnccn.2023.7041 PMID:37673109
91. Hanly P, Ortega MO, Pearce A, Cancela MD, Soerjomataram I, Sharp L (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. Pharmacoeconomics. 41(9): 1093-1101. https://doi.org/10.1007/s40273-023-01261-y PMID:37036642
92. Jubber I, Ong S, Bukavina L, Black PC, Comperat E, Kamat AM, et al. (2023). Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. European Urology. 84(2): 176-190. https://doi.org/10.1016/j.eururo.2023.03.029 PMID:37198015
93. Kidayi PL, Pakpour AH, Saboonchi F, Bray F, Manhica H, Mtuya CC, et al. (2023). Cross-Cultural Adaptation and Psychometric Properties of the Swahili Version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR45 among Breast Cancer Patients in Tanzania. Healthcare (Basel). 11(18): 15. https://doi.org/10.3390/healthcare11182467 PMID:37761665
94. Kiss Z, Kocsis J, Nikolenyi A, Horvath Z, Knollmajer K, Benedek A, et al. (2023). Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020. Frontiers in Oncology. 13: 1182170. https://doi.org/10.3389/fonc.2023.1182170 PMID:37795445
95. Laronningen S, Skog A, Engholm G, Ferlay J, Johannesen TB, Kristiansen MF, et al. (2023). Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data. Frontiers in Oncology. 13: 1098342. https://doi.org/10.3389/fonc.2023.1098342 PMID:37614501
96. Li M, Meheus F, Polazzi S, Delafosse P, Borson-Chazot F, Seigneurin A, et al. (2023). The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases. Value in Health. 26(8): 1175-1182. https://doi.org/10.1016/j.jval.2023.02.016 PMID:36921898
97. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID:36241389
98. Liu B, Abraham N, Chitsike I, Sylvie CGL, Kambugu J, Stevy NMA, et al. (2023). Enhancing information on stage at diagnosis for childhood cancer in Africa. Pediatric Blood & Cancer. 70(10): e30555. https://doi.org/10.1002/pbc.30555 PMID:37432023
99. Luo G, Zhang Y, Etxeberria J, Arnold M, Cai X, Hao Y, et al. (2023). Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study. JMIR Public Health Surveill. 9(1): e43651. https://doi.org/10.2196/43651 PMID:36800235
100. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers and Prevention. 32(1): 132-140. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID:36306379
101. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J (2023). Cancer survival in the northwestern of Sao Paulo State, Brazil: A population-based study. Cancer Epidemiology. 83: 102339. https://doi.org/10.1016/j.canep.2023.102339 PMID:36863216
102. Mallon B, Kabore R, Couitchere L, Akonde FB, Narison MLR, Budiongo A, et al. (2023). The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group. Pediatric Blood & Cancer. 70(12): e30664. https://doi.org/10.1002/pbc.30664 PMID:37732944
103. Marant Micallef C, Charvat H, Houot MT, Vignat J, Straif K, Paul A, et al. (2023). Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates. Journal of Exposure Science & Environmental Epidemiology. 33(1): 125-131. https://doi.org/10.1038/s41370-021-00353-1 PMID:34172838
104. Mohar A, Paredes A, Brau-Figueroa H, Sanchez A, Palafox A, Rivera-Gomez R, et al. (2023). [Not Available]. Salud Publica de México. 66(1, ene-feb): 104-112. https://doi.org/10.21149/15258 PMID:38065103
105. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 72(2): 338-344. https://doi.org/10.1136/gutjnl-2022-327736 PMID:36604116
106. Morgan E, O’Neill C, Bardot A, Walsh P, Soerjomataram I, Arnold M (2023). The Challenges of Collecting Long-Term Outcomes in Cancer Patients on the Population-Level: The Case of Metastatic Breast Cancer. J Registry Manag. 50(4): 173-175. PMID:38504704
107. Myklebust TA, Aagnes B, Nilssen Y, Rutherford M, Lambert PC, Andersson TML, et al. (2023). Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications. British Journal of Cancer. 129(5): 819-828. https://doi.org/10.1038/s41416-023-02360-5 PMID:37433898
108. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2023). Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040. Appl Health Econ Health Policy. 21(6): 877-889. https://doi.org/10.1007/s40258-023-00824-6 PMID:37552416
109. Parkin DM, Liu B, Adoubi I, Makouanzi AS, Masalu N, Mrema C, et al. (2023). Enhancing information on stage at diagnosis of cancer in Africa. Acta Oncologica. 62(4): 335-341. https://doi.org/10.1080/0284186X.2023.2205548 PMID:37102435
110. Pineros M, Brierley J, Barrios E, Cueva P, Musetti C, Pardo C, et al. (2023). Accuracy of Essential TNM to stage large colorectal (T3/T4) cancers in absence of nodal status information. Acta Oncologica. 62(12): 1669-1671. https://doi.org/10.1080/0284186X.2023.2257376 PMID:37738263
111. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F (2023). Thyroid Cancer Incidence and Mortality by Socioeconomic Level in the State of São Paulo, Brazil 2001-2017. Endocrine Practice. 29(10): 770-778. https://doi.org/10.1016/j.eprac.2023.07.028 PMID:37536501
112. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F (2023). Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17. Cancer Med. 12(15): 16615-16625. https://doi.org/10.1002/cam4.6259 PMID:37345901
113. Ritter J, Allen S, Cohen PD, Fajardo AF, Marx K, Loggetto P, et al. (2023). Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncology. 24(9): e364-e375. https://doi.org/10.1016/S1470-2045(23)00320-0 PMID:37657477
114. Roshandel G, Badar F, Barchuk A, Roder DM, Sangrajrang S, Mery L, et al. (2023). REPCAN: Guideline for REporting Population-based CANcer Registry Data. Asian Pacific Journal of Cancer Prevention. 24(9): 3297-3303. https://doi.org/10.31557/APJCP.2023.24.9.3297 PMID:37777857
115. Rumgay H, Cabasag CJ, Offman J, de Camargo Cancela M, Barchuk A, Mathur P, et al. (2023). International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States. EClinicalMedicine. 66: 102289. https://doi.org/10.1016/j.eclinm.2023.102289 PMID:38192589
116. Rumgay H, Ortega-Ortega M, Sharp L, Lunet N, Soerjomataram I (2023). The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018. Cancer Epidemiology. 84: 102365. https://doi.org/10.1016/j.canep.2023.102365 PMID:37058915
117. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, et al. (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17: 1553. https://doi.org/10.3332/ecancer.2023.1553 PMID:37377679
118. Schmutz A, Matta M, Cairat M, Espina C, Schuz J, Kampman E, et al. (2023). Mapping the European cancer prevention research landscape: A case for more prevention research funding. European Journal of Cancer. 195: 113378. https://doi.org/10.1016/j.ejca.2023.113378 PMID:37924646
119. Schuz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiology. 86 Suppl 1: 102453. https://doi.org/10.1016/j.canep.2023.102453 PMID:37852730
120. Schuz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, et al. (2023). Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental Health: A Global Access Science Source. 22(1): 13. https://doi.org/10.1186/s12940-022-00952-x PMID:36703177
121. Sedeta E, Sung H, Laversanne M, Bray F, Jemal A (2023). Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide. Cancer Epidemiology, Biomarkers and Prevention. 32(7): 894-905. https://doi.org/10.1158/1055-9965.EPI-22-1133 PMID:37195435
122. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID:36528031
123. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al. (2023). Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24(1): 22-32. https://doi.org/10.1016/S1470-2045(22)00704-5 PMID:36603919
124. Song CV, van Gils CH, Yip CH, Soerjomataram I, Taib NAM, See MH, et al. (2023). Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting. Diagnostics (Basel). 13(4): 674. https://doi.org/10.3390/diagnostics13040674 PMID:36832162
125. Storm HH, Laronningen S, Bray F (2023). Do investments in cancer registry databases and tools bring added value? NORDCAN as an example. Acta Oncologica. 62(6): 535-540. https://doi.org/10.1080/0284186X.2023.2218557 PMID:37276272
126. Vaccarella S, Georges D, Bray F, Ginsburg O, Charvat H, Martikainen P, et al. (2023). Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study. Lancet Reg Health Eur. 25: 100551. https://doi.org/10.1016/j.lanepe.2022.100551 PMID:36818237
127. Weber A, Laversanne M, Nagy P, Kenessey I, Soerjomataram I, Bray F (2023). Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 European countries 1995-2019. European Journal of Epidemiology. 38(11): 1141-1152. https://doi.org/10.1007/s10654-023-01039-8 PMID:37676425
128. Weber A, Mery L, Nagy P, Polgar C, Bray F, Kenessey I (2023). Evaluation of data quality at the Hungarian National Cancer Registry, 2000-2019. Cancer Epidemiology. 82: 102306. https://doi.org/10.1016/j.canep.2022.102306 PMID:36521336
129. Weber A, Morgan E, Vignat J, Laversanne M, Pizzato M, Rumgay H, et al. (2023). Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 13(5): e065303. https://doi.org/10.1136/bmjopen-2022-065303 PMID:37164477
130. Wu L, Vaccarella S, Feng CY, Dal Maso L, Chen Y, Liu WW, et al. (2023). Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur Thyroid J. 12(6): e230127. https://doi.org/10.1530/ETJ-23-0127 PMID:37855414
131. Xu J, Xu W, Choi J, Brhane Y, Christiani DC, Kothari J, et al. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. Plos Genetics. 19(9): e1010902. https://doi.org/10.1371/journal.pgen.1010902 PMID:37738239
132. Youlden DR, Steliarova-Foucher E, Gini A, Silva NP, Aitken JFJ (2023). The growing prevalence of childhood cancer survivors in Australia. Pediatric Blood & Cancer. 70(7): e30383. https://doi.org/10.1002/pbc.30383 PMID:37092826
133. Zhang Y, Rumgay H, Li M, Cao S, Chen W (2023). Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health Surveill. 9: e49968. https://doi.org/10.2196/49968 PMID:37728964
134. Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J (2023). The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 13: 04109. https://doi.org/10.7189/jogh.13.04109 PMID:37712386
135. Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. (2023). Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncology. 24(11): 1206-1218. https://doi.org/10.1016/S1470-2045(23)00444-8 PMID:37837979
136. Zheng R, Wang S, Zhang S, Zeng H, Chen R, Sun K, et al. (2023). Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 68(21): 2620-2628. https://doi.org/10.1016/j.scib.2023.09.041 PMID:37821267
137. Znaor A, Ryzhov A, Losada ML, Carvalho A, Smelov V, Barchuk A, et al. (2023). Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 38: 100436. https://doi.org/10.1016/j.jcpo.2023.100436 PMID:37544479
138. Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, et al. (2023). Global epidemiologic patterns of oropharyngeal cancer incidence trends. Journal of the National Cancer Institute. 115(12): 1544-1554. https://doi.org/10.1093/jnci/djad169 PMID:37603716
139. Alkhalawi E, Znaor A, Al-Zahrani AS (2022). Quality of data from cancer registries in the Eastern Mediterranean region. Lancet Oncology. 23(4): 449-451. https://doi.org/10.1016/S1470-2045(22)00072-9 PMID:35358450
140. Andersson TM, Myklebust TA, Rutherford MJ, Moller B, Arnold M, Soerjomataram I, et al. (2022). Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2. British Journal of Cancer. 126(8): 1224-1228. https://doi.org/10.1038/s41416-022-01701-0 PMID:35058590
141. Andersson TM, Rutherford MJ, Myklebust TA, Moller B, Arnold M, Soerjomataram I, et al. (2022). A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2. Cancer Epidemiology. 76: 102085. https://doi.org/10.1016/j.canep.2021.102085 PMID:34954495
142. Araghi M, Fidler-Benaoudia M, Arnold M, Rutherford M, Bardot A, Ferlay J, et al. (2022). International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 77(4): 378-390. https://doi.org/10.1136/thoraxjnl-2020-216555 PMID:34282033
143. Arnold M, Morgan E, Bardot A, Rutherford MJ, Ferlay J, Little A, et al. (2022). International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 71(8): 1532-1543. https://doi.org/10.1136/gutjnl-2021-325266 PMID:34824149
144. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. https://doi.org/10.1016/j.breast.2022.08.010 PMID:36084384
145. Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. (2022). Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 158(5): 495-503. https://doi.org/10.1001/jamadermatol.2022.0160 PMID:35353115
146. Banack HR, Chang J, Stefanick ML, Arnold M, Anton-Culver H, Jiang L (2022). Relationship between BMI trajectories and cardiometabolic outcomes in postmenopausal women: a growth mixture modeling approach. Annals of Epidemiology. 72: 9-17. https://doi.org/10.1016/j.annepidem.2022.04.004 PMID:35469929
147. Bravo LE, Garcia LS, Collazos P, Holguin J, Soerjomataram I, Miranda-Filho A (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. https://doi.org/10.25100/cm.v53i1.5082 PMID:36452118
148. Bray F, Parkin DM, African Cancer Registry N (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 23(6): 719-728. https://doi.org/10.1016/S1470-2045(22)00270-4 PMID:35550275
149. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. https://doi.org/10.1016/j.eururo.2022.08.019 PMID:36100483
150. Byrne J, Schmidtmann I, Rashid H, Hagberg O, Bagnasco F, Bardi E, et al. (2022). Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. International Journal of Cancer. 150(3): 406-419. https://doi.org/10.1002/ijc.33817 PMID:34551126
151. Cabasag CJ, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E, et al. (2022). Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. British Journal of Cancer. 126(12): 1774-1782. https://doi.org/10.1038/s41416-022-01752-3 PMID:35236937
152. Cabasag CJ, Fagan PJ, Ferlay J, Vignat J, Laversanne M, Liu L, et al. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. International Journal of Cancer. 151(9): 1535-1541. https://doi.org/10.1002/ijc.34002 PMID:35322413
153. Cabasag CJ, Ferlay J, Laversanne M, Vignat J, Weber A, Soerjomataram I, et al. (2022). Pancreatic cancer: an increasing global public health concern. Gut. 71(8): 1686-1687. https://doi.org/10.1136/gutjnl-2021-326311 PMID:34686577
154. Cabasag CJ, Vignat J, Ferlay J, Arndt V, Lemmens V, Praagman J, et al. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. European Journal of Cancer. 177: 15-24. https://doi.org/10.1016/j.ejca.2022.09.030 PMID:36323048
155. Carle C, Hughes S, Freeman V, Campbell D, Egger S, Caruana M, et al. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. J Cancer Policy. 33: 100338. https://doi.org/10.1016/j.jcpo.2022.100338 PMID:35671919
156. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F, et al. (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1): 231-241. https://doi.org/10.1016/j.ygyno.2021.10.073 PMID:34716024
157. Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, et al. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiology, Biomarkers and Prevention. 31(2): 325-333. https://doi.org/10.1158/1055-9965.EPI-21-0688 PMID:34782393
158. De Camargo Cancela M, Bezerra de Souza DL, Leite Martins LF, Borges L, Schilithz AO, Hanly P, et al. (2022). Can the sustainable development goals for cancer be met in Brazil? A population-based study. Frontiers in Oncology. 12: 1060608. https://doi.org/10.3389/fonc.2022.1060608 PMID:36703792
159. de Camargo Cancela M, de Oliveira Santos M, Migowski A, Pineros M (2022). Breast cancer among young women in Brazil: Differences between hospital and population-based series. Cancer Epidemiology. 79: 102193. https://doi.org/10.1016/j.canep.2022.102193 PMID:35696767
160. Dee EC, Eala MAB, Chua MLK, Bray F, Bhoo-Pathy N (2022). Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective. Pediatric Blood & Cancer. 69(7): e29593. https://doi.org/10.1002/pbc.29593 PMID:35129873
161. Dee EC, Santos PMG, Bray F (2022). The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research. Asia-Pacific Journal of Clinical Oncology. 18(5): e524-e525. https://doi.org/10.1111/ajco.13738 PMID:35098661
162. Doganis D, Karalexi MA, group N-Sc, Panagopoulou P, Bouka P, Bouka E, et al. (2022). Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA. Cancer Epidemiology. 78: 102153. https://doi.org/10.1016/j.canep.2022.102153 PMID:35390585
163. Freeman V, Hughes S, Carle C, Campbell D, Egger S, Hui H, et al. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy. 33: 100340. https://doi.org/10.1016/j.jcpo.2022.100340 PMID:35680113
164. Gil F, Miranda-Filho A, Uribe-Perez C, Arias-Ortiz NE, Yepez-Chamorro MC, Bravo LM, et al. (2022). Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries. Journal of Cancer Epidemiology. 2022: 9068214. https://doi.org/10.1155/2022/9068214 PMID:35140789
165. Gini A, Selby K (2022). Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population? Clinical Gastroenterology and Hepatology. 20(10): 2216-2217. https://doi.org/10.1016/j.cgh.2022.03.030 PMID:35390510
166. Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, et al. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. https://doi.org/10.1038/s41591-022-02109-2 PMID:36404355
167. Hanly P, Ortega-Ortega M, Soerjomataram I (2022). Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach. Current Oncology (Toronto, Ont.). 29(5): 3552-3564. https://doi.org/10.3390/curroncol29050287 PMID:35621677
168. Ibrahim Khalil A, Franceschi S, de Martel C, Bray F, Clifford GM (2022). Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. International Journal of Cancer. 150(12): 1948-1957. https://doi.org/10.1002/ijc.33951 PMID:35085400
169. Ibrahim Khalil A, Mpunga T, Wei F, Baussano I, de Martel C, Bray F, et al. (2022). Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International Journal of Cancer. 150(5): 761-772. https://doi.org/10.1002/ijc.33841 PMID:34626498
170. Ilbawi AM, Lam CG, Ortiz R, Bray F (2022). Investing in childhood cancer registries to drive progress. Lancet Child Adolesc Health. 6(7): 446-447. https://doi.org/10.1016/S2352-4642(22)00148-1 PMID:35605627
171. Kenessey I, Szoke G, Dobozi M, Szatmari I, Weber A, Fogarassy G, et al. (2022). Comparison of Cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based Cancer Registry. Pathology Oncology Research. 28: 1610668. https://doi.org/10.3389/pore.2022.1610668 PMID:36147657
172. Kiss Z, Wittmann I, Polivka L, Surjan G, Surjan O, Barcza Z, et al. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. 13: 905585. https://doi.org/10.3389/fimmu.2022.905585 PMID:35812442
173. Kiss ZN, Bogos K, Tamasi L, Ostoros G, Muller V, Bittner N, et al. (2022). Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study). Frontiers in Oncology. 12: 1032366. https://doi.org/10.3389/fonc.2022.1032366 PMID:36505881
174. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. https://doi.org/10.1186/s12885-022-09589-y PMID:35568802
175. Leal YA, Torres J, Gamboa R, Mantilla-Morales A, Pina-Sanchez P, Arrieta O, et al. (2022). Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry. Archives of Medical Research. 53(8): 859-866. https://doi.org/10.1016/j.arcmed.2022.11.015 PMID:36462950
176. Li M, Zhang L, Charvat H, Callister ME, Sasieni P, Christodoulou E, et al. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. https://doi.org/10.1002/ijc.34167 PMID:35809038
177. Lorenzoni V, Chaturvedi AK, Vignat J, Laversanne M, Bray F, Vaccarella S (2022). The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. Cancer Epidemiology, Biomarkers and Prevention. 31(11): 2054-2062. https://doi.org/10.1158/1055-9965.EPI-22-0642 PMID:36173880
178. Luo Q, Lew JB, Steinberg J, Worthington J, Yu XQ, Caruana M, et al. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports. 12(1): 3994. https://doi.org/10.1038/s41598-022-07797-x PMID:35256697
179. Luo Q, O’Connell DL, Yu XQ, Kahn C, Caruana M, Pesola F, et al. (2022). Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 7(6): e537-e548. https://doi.org/10.1016/S2468-2667(22)00090-1 PMID:35660215
180. Mafra A, Laversanne M, Gospodarowicz M, Klinger P, De Paula Silva N, Pineros M, et al. (2022). Global patterns of non-Hodgkin lymphoma in 2020. International Journal of Cancer. 151(9): 1474-1481. https://doi.org/10.1002/ijc.34163 PMID:35695282
181. Mafra da Costa A, Hernandes ICP, Weiderpass E, Soerjomataram I, Fregnani J (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiology, Biomarkers and Prevention. 31(4): 707-714. https://doi.org/10.1158/1055-9965.EPI-21-0842 PMID:35131883
182. Malakova K, Cabasag CJ, Bardot A, Sangrajrang S, Chitapanarux I, Sripan P, et al. (2022). Cancer survival in Thailand from 1997 to 2012: Assessing the impact of universal health coverage. J Cancer Policy. 34: 100353. https://doi.org/10.1016/j.jcpo.2022.100353 PMID:36357312
183. Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 47: 101404. https://doi.org/10.1016/j.eclinm.2022.101404 PMID:35497064
184. Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. (2022). The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 163(3): 649-658 e642. https://doi.org/10.1053/j.gastro.2022.05.054 PMID:35671803
185. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Mohebbi E, Ravankhah Z, et al. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. International Journal of Cancer. 151(12): 2128-2135. https://doi.org/10.1002/ijc.34224 PMID:35869869
186. Nemati S, Saeedi E, Roshandel G, Nahvijou A, Badakhshan A, Akbari M, et al. (2022). Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012. Cancer Epidemiology. 77: 102089. https://doi.org/10.1016/j.canep.2021.102089 PMID:35042146
187. Noll F, Adams T, Cohen R, Soerjomataram I, Reid F (2022). Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman Study. International Journal of Gynecological Cancer. 32(8): 1080-1081. https://doi.org/10.1136/ijgc-2022-003449 PMID:35314459
188. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2022). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4): 580-593. https://doi.org/10.1002/ijc.33826 PMID:34569617
189. Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, et al. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. https://doi.org/10.1158/1055-9965.EPI-22-0376 PMID:36126276
190. Payne NWS, Brown KF, Delon C, Kotrotsios Y, Soerjomataram I, Shelton J (2022). Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PloS One. 17(9): e0272202. https://doi.org/10.1371/journal.pone.0272202 PMID:36129905
191. Persson MSM, Yin W, Doring N, Risnes K, Weiderpass E, Steliarova-Foucher E, et al. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. International Journal of Cancer. 150(8): 1269-1280. https://doi.org/10.1002/ijc.33886 PMID:34855204
192. Pierannunzio D, Fedeli U, Francisci S, Paoli A, Toffolutti F, Serraino D, et al. (2022). Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018. Thyroid. 32(3): 263-272. https://doi.org/10.1089/thy.2021.0531 PMID:35018816
193. Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, et al. (2022). International trends in cancer incidence in middle-aged and older adults in 44 countries. Journal of Geriatric Oncology. 13(3): 346-355. https://doi.org/10.1016/j.jgo.2021.11.011 PMID:34866023
194. Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, et al. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). https://doi.org/10.3390/cancers14061529 PMID:35326681
195. Pineros M (2022). Evaluation and variability of quality in mortality statistics in Colombia: the importance of detail. REVISTA COLOMBIANA DE CANCEROLOGIA. 26(3): 241-243.
196. Pineros M, Ginsburg O, Bendahhou K, Eser S, Shelpai WA, Fouad H, et al. (2022). Staging practices and breast cancer stage among population-based registries in the MENA region. Cancer Epidemiology. 81: 102250. https://doi.org/10.1016/j.canep.2022.102250 PMID:36115143
197. Pineros M, Laversanne M, Barrios E, Cancela MC, de Vries E, Pardo C, et al. (2022). An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 13: None. https://doi.org/10.1016/j.lana.2022.100294 PMID:36189115
198. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. (2022). The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes and Endocrinology. 10(4): 264-272. https://doi.org/10.1016/S2213-8587(22)00035-3 PMID:35271818
199. Pizzato M, Martinsen JI, Heikkinen S, Vignat J, Lynge E, Sparen P, et al. (2022). Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries. Cancer Med. 11(8): 1850-1859. https://doi.org/10.1002/cam4.4548 PMID:35166068
200. Roel E, Pistillo A, Recalde M, Fernandez-Bertolin S, Aragon M, Soerjomataram I, et al. (2022). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. International Journal of Cancer. 150(5): 782-794. https://doi.org/10.1002/ijc.33846 PMID:34655476
201. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. (2022). Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology. 77(6): 1598-1606. https://doi.org/10.1016/j.jhep.2022.08.021 PMID:36208844
202. Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. (2022). Global, regional and national burden of primary liver cancer by subtype. European Journal of Cancer. 161: 108-118. https://doi.org/10.1016/j.ejca.2021.11.023 PMID:34942552
203. Sarich P, Cabasag CJ, Liebermann E, Vaneckova P, Carle C, Hughes S, et al. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 47: 101375. https://doi.org/10.1016/j.eclinm.2022.101375 PMID:35434579
204. Singh D, Vaccarella S, Gini A, De Paula Silva N, Steliarova-Foucher E, Bray F (2022). Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040. International Journal of Cancer. 150(12): 1941-1947. https://doi.org/10.1002/ijc.33948 PMID:35080783
205. Smith L, Stiller CA, Aitken JF, Hjalgrim LL, Johannesen T, Lahteenmaki P, et al. (2022). International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries. International Journal of Cancer. 150(1): 28-37. https://doi.org/10.1002/ijc.33774 PMID:34449879
206. Soerjomataram I, Bardot A, Aitken J, Pineros M, Znaor A, Steliarova-Foucher E, et al. (2022). Impact of the COVID-19 pandemic on population-based cancer registry. International Journal of Cancer. 150(2): 273-278. https://doi.org/10.1002/ijc.33792 PMID:34480348
207. Soerjomataram I, Bray F, Lansdorp-Vogelaar I, Ginsburg O, Rahal R, Sullivan R, et al. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. J Cancer Policy. 32: 100328. https://doi.org/10.1016/j.jcpo.2022.100328 PMID:35560265
208. Soo R, Mery L, Bardot A, Kanesvaran R, Keong TC, Pongnikorn D, et al. (2022). Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries. ESMO Open. 7(5): 100560. https://doi.org/10.1016/j.esmoop.2022.100560 PMID:35988454
209. Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, et al. (2022). Global challenges and policy solutions in breast cancer control. Cancer Treatment Reviews. 104: 102339. https://doi.org/10.1016/j.ctrv.2022.102339 PMID:35074727
210. Voko Z, Kiss Z, Surjan G, Surjan O, Barcza Z, Wittmann I, et al. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. 13: 919408. https://doi.org/10.3389/fimmu.2022.919408 PMID:35935993
211. Wang S, Zheng R, Arnold M, Abnet C, Zeng H, Zhang S, et al. (2022). Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype. International Journal of Cancer. 151(9): 1447-1461. https://doi.org/10.1002/ijc.34158 PMID:35678331
212. Weber A, Szatmari I, Dobozi M, Hilbert L, Branyiczkine Geczy G, Nagy P, et al. (2022). [Comparison of Hungarian Central Statistical Office’s causes of death data with the database of the Hungarian National Cancer Registry]. Orvosi Hetilap. 163(37): 1481-1489. https://doi.org/10.1556/650.2022.32573 PMID:36088625
213. Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S, Nicholson B, et al. (2022). Current and projected number of years of life lost due to prostate cancer: A global study. Prostate. 82(11): 1088-1097. https://doi.org/10.1002/pros.24360 PMID:35468227
214. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2022). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tobacco Control. https://doi.org/10.1136/tc-2022-057262 PMID:36100264
215. Znaor A, Corbex M, Cao B, Laversanne M, Ryzhov A, Smelov V, et al. (2022). Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000-19. European Journal of Public Health. 32(4): 624-629. https://doi.org/10.1093/eurpub/ckac030 PMID:35441219
216. Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Kulis T, Laversanne M, Gurney J, et al. (2022). Global patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer. 151(5): 692-698. https://doi.org/10.1002/ijc.33999 PMID:35277970
217. Amosa-Lei Sam F, Akinremi A, Mery L, Sarfati D, Stanley J, Gurney J (2021). Cancer Incidence in Samoa: A 10-Year Retrospective Survey (2007-2016). Asia-Pacific Journal of Public Health. 33(6-7): 700-706. https://doi.org/10.1177/1010539520975261 PMID:33233921
218. Andersson TM, Myklebust TA, Rutherford MJ, Moller B, Soerjomataram I, Arnold M, et al. (2021). The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiology. 71(Pt A): 101881. https://doi.org/10.1016/j.canep.2020.101881 PMID:33440295
219. Andersson TM, Rutherford MJ, Myklebust TA, Moller B, Soerjomataram I, Arnold M, et al. (2021). Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. British Journal of Cancer. 124(5): 1026-1032. https://doi.org/10.1038/s41416-020-01196-7 PMID:33293692
220. Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, et al. (2021). Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 70(1): 114-126. https://doi.org/10.1136/gutjnl-2020-320625 PMID:32482683
221. Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P, et al. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. International Journal of Cancer. 148(2): 277-284. https://doi.org/10.1002/ijc.33189 PMID:32638362
222. Barchuk A, Belyaev A, Gretsova O, Tursun-Zade R, Moshina N, Znaor A (2021). History and current status of cancer registration in Russia. Cancer Epidemiology. 73: 101963. https://doi.org/10.1016/j.canep.2021.101963 PMID:34089992
223. Barchuk A, Tursun-Zade R, Belayev A, Moore M, Komarov Y, Moshina N, et al. (2021). Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncologica. 60(10): 1264-1271. https://doi.org/10.1080/0284186X.2021.1967443 PMID:34424113
224. Bonjour M, Charvat H, Franco EL, Pineros M, Clifford GM, Bray F, et al. (2021). Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 6(7): e510-e521. https://doi.org/10.1016/S2468-2667(21)00046-3 PMID:33864738
225. Bray F, Laversanne M, Cao B, Varghese C, Mikkelsen B, Weiderpass E, et al. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treatment Reviews. 100: 102290. https://doi.org/10.1016/j.ctrv.2021.102290 PMID:34536729
226. Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021). The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16): 3029-3030. https://doi.org/10.1002/cncr.33587 PMID:34086348
227. Bukirwa P, Wabinga H, Nambooze S, Amulen PM, Joko WY, Liu B, et al. (2021). Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. International Journal of Cancer. 148(9): 2129-2138. https://doi.org/10.1002/ijc.33373 PMID:33129228
228. Cabasag CJ, Arnold M, Pineros M, Morgan E, Brierley J, Hofferkamp J, et al. (2021). Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2. International Journal of Cancer. 149(6): 1239-1246. https://doi.org/10.1002/ijc.33679 PMID:33990959
229. Conway DI, Hovanec J, Ahrens W, Ross A, Holcatova I, Lagiou P, et al. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. Journal of Epidemiology and Community Health. 75(8): 779-787. https://doi.org/10.1136/jech-2020-214913 PMID:33622804
230. Crocetti E, Mattioli V, Buzzoni C, Franceschi S, Serraino D, Vaccarella S, et al. (2021). Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012. Cancer Med. 10(19): 6855-6867. https://doi.org/10.1002/cam4.4193 PMID:34533289
231. Dal Maso L, Panato C, De Paoli A, Mattioli V, Serraino D, Elisei R, et al. (2021). Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy. Journal of Endocrinological Investigation. 44(8): 1679-1688. https://doi.org/10.1007/s40618-020-01475-3 PMID:33460012
232. Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, et al. (2021). National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncology. 22(11): 1632-1642. https://doi.org/10.1016/S1470-2045(21)00462-9 PMID:34653370
233. Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. European Journal of Cancer. 157: 308-347. https://doi.org/10.1016/j.ejca.2021.07.039 PMID:34560371
234. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer. 149(4): 778-789. https://doi.org/10.1002/ijc.33588 PMID:33818764
235. Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. (2021). Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 4(6): 877-892. https://doi.org/10.1016/j.euo.2021.09.006 PMID:34716119
236. Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, et al. (2021). Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clinic Proceedings. 96(11): 2823-2830. https://doi.org/10.1016/j.mayocp.2021.04.028 PMID:34736609
237. Gredner T, Mons U, Niedermaier T, Brenner H, Soerjomataram I (2021). Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study. Lancet Reg Health Eur. 4: 100074. https://doi.org/10.1016/j.lanepe.2021.100074 PMID:34029359
238. Gullickson C, Goodman M, Joko-Fru YW, Gnangnon FHR, N’Da G, Woldegeorgis MA, et al. (2021). Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. International Journal of Cancer. 149(8): 1553-1563. https://doi.org/10.1002/ijc.33715 PMID:34164808
239. Johnson S, Tittenbrun Z, Romero Y, Torode J, Frech S, Abdel-Wahab M, et al. (2021). The World Cancer Declaration: time to consolidate wins and work towards 2025. Lancet Oncology. 22(3): 296-298. https://doi.org/10.1016/S1470-2045(21)00012-7 PMID:33548178
240. Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schuz J, Roman E (2021). Childhood cancer: Estimating regional and global incidence. Cancer Epidemiology. 71(Pt B): 101662. https://doi.org/10.1016/j.canep.2019.101662 PMID:31924557
241. Kilian C, Rovira P, Neufeld M, Ferreira-Borges C, Rumgay H, Soerjomataram I, et al. (2021). Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region. Lancet Reg Health Eur. 11: 100225. https://doi.org/10.1016/j.lanepe.2021.100225 PMID:34918000
242. Li M, Delafosse P, Meheus F, Borson-Chazot F, Lifante JC, Simon R, et al. (2021). Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiology. 75: 102051. https://doi.org/10.1016/j.canep.2021.102051 PMID:34743057
243. Li M, Zheng R, Dal Maso L, Zhang S, Wei W, Vaccarella S (2021). Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes and Endocrinology. 9(6): 330-332. https://doi.org/10.1016/S2213-8587(21)00083-8 PMID:33891886
244. Liu B, Youlden DR, Wabinga H, Nambooze S, Amulen PM, Aitken JF, et al. (2021). Survival from childhood cancer in Kampala, Uganda. Pediatric Blood & Cancer. 68(3): e28876. https://doi.org/10.1002/pbc.28876 PMID:33381877
245. Longatto-Filho A, Fregnani JH, Mafra da Costa A, de Araujo-Souza PS, Scapulatempo-Neto C, Herbster S, et al. (2021). Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity. Acta Cytologica. 65(2): 165-174. https://doi.org/10.1159/000512010 PMID:33271565
246. Mafra da Costa A, Ribeiro AL, Ribeiro AG, Gini A, Cabasag C, Reis RM, et al. (2021). Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil. Cancer Control. 28: 10732748211038736. https://doi.org/10.1177/10732748211038736 PMID:34406894
247. Mandrik O, Tolma E, Zielonke N, Meheus F, Ordonez-Reyes C, Severens JL, et al. (2021). Systematic reviews as a “lens of evidence”: Determinants of participation in breast cancer screening. Journal of Medical Screening. 28(2): 70-79. https://doi.org/10.1177/0969141320930743 PMID:32517538
248. Marant Micallef C, Paul A, Charvat H, Vignat J, Houot M, Pilorget C, et al. (2021). An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France. Journal of Exposure Science & Environmental Epidemiology. 31(4): 769-776. https://doi.org/10.1038/s41370-020-00272-7 PMID:33144638
249. Miranda-Filho A, Charvat H, Bray F, Migowski A, Cheung LC, Vaccarella S, et al. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. https://doi.org/10.1016/j.eclinm.2021.101176 PMID:34765952
250. Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. (2021). Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes and Endocrinology. 9(4): 225-234. https://doi.org/10.1016/S2213-8587(21)00027-9 PMID:33662333
251. Morgan E, Arnold M, Rutherford MJ, Bardot A, Ferlay J, De P, et al. (2021). The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). International Journal of Cancer. 149(5): 1013-1020. https://doi.org/10.1002/ijc.33620 PMID:33932300
252. Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, et al. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 70(2): 234-242. https://doi.org/10.1136/gutjnl-2020-321089 PMID:32554620
253. Musetti C, Garau M, Alonso R, Pineros M, Soerjomataram I, Barrios E (2021). Colorectal Cancer in Young and Older Adults in Uruguay: Changes in Recent Incidence and Mortality Trends. International Journal of Environmental Research and Public Health. 18(15): 8232. https://doi.org/10.3390/ijerph18158232 PMID:34360522
254. Parkin DM, Chingonzoh T, Vuma S, Liu B, Chokunonga E, Ndlovu N, et al. (2021). Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiology, Biomarkers and Prevention. 30(5): 867-873. https://doi.org/10.1158/1055-9965.EPI-20-0669 PMID:33619023
255. Parkin DM, Youlden DR, Chitsike I, Chokunonga E, Couitchere L, Gnahatin F, et al. (2021). Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa. International Journal of Cancer. 148(11): 2685-2691. https://doi.org/10.1002/ijc.33468 PMID:33433927
256. Perera SK, Jacob S, Wilson BE, Ferlay J, Bray F, Sullivan R, et al. (2021). Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. Lancet Oncology. 22(2): 182-189. https://doi.org/10.1016/S1470-2045(20)30675-6 PMID:33485458
257. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, et al. (2021). Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. International Journal of Cancer. 148(7): 1575-1585. https://doi.org/10.1002/ijc.33326 PMID:33006395
258. Pilleron S, Maringe C, Charvat H, Atkinson J, Morris E, Sarfati D (2021). Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung Cancer. 157: 92-99. https://doi.org/10.1016/j.lungcan.2021.05.015 PMID:34006378
259. Pilleron S, Maringe C, Charvat H, Atkinson J, Morris EJA, Sarfati D (2021). The impact of timely cancer diagnosis on age disparities in colon cancer survival. Journal of Geriatric Oncology. 12(7): 1044-1051. https://doi.org/10.1016/j.jgo.2021.04.003 PMID:33863698
260. Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F, et al. (2021). Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. International Journal of Cancer. 148(3): 601-608. https://doi.org/10.1002/ijc.33232 PMID:32706917
261. Pineros M, Abriata MG, de Vries E, Barrios E, Bravo LE, Cueva P, et al. (2021). Progress, challenges and ways forward supporting cancer surveillance in Latin America. International Journal of Cancer. 149(1): 12-20. https://doi.org/10.1002/ijc.33407 PMID:33231289
262. Pineros M, Mery L, Soerjomataram I, Bray F, Steliarova-Foucher E (2021). Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap. Journal of the National Cancer Institute. 113(1): 9-15. https://doi.org/10.1093/jnci/djaa069 PMID:32433739
263. Pineros M, Saraiya M, Baussano I, Bonjour M, Chao A, Bray F (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Preventive Medicine. 144: 106237. https://doi.org/10.1016/j.ypmed.2020.106237 PMID:33678223
264. Puyol M, Seoane J, Aguilar E, Vozza LB, Orbe I, Crawford KH, et al. (2021). WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer. Clinical Cancer Research. 27(4): 963-966. https://doi.org/10.1158/1078-0432.CCR-20-2978 PMID:33257425
265. Roel E, Pistillo A, Recalde M, Sena AG, Fernandez-Bertolin S, Aragon M, et al. (2021). Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiology, Biomarkers and Prevention. 30(10): 1884-1894. https://doi.org/10.1158/1055-9965.EPI-21-0266 PMID:34272262
266. Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. 149(3): 594-605. https://doi.org/10.1002/ijc.33574 PMID:33884608
267. Rovira P, Kilian C, Neufeld M, Rumgay H, Soerjomataram I, Ferreira-Borges C, et al. (2021). Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study. European Addiction Research. 27(3): 189-197. https://doi.org/10.1159/000511899 PMID:33271557
268. Rumgay H, Arnold M, Laversanne M, Whiteman DC, Thrift AP, Wei W, et al. (2021). International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. American Journal of Gastroenterology. 116(5): 1072-1076. https://doi.org/10.14309/ajg.0000000000001121 PMID:33929382
269. Rumgay H, Murphy N, Ferrari P, Soerjomataram I (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 13(9). https://doi.org/10.3390/nu13093173 PMID:34579050
270. Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, et al. (2021). Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncology. 22(8): 1071-1080. https://doi.org/10.1016/S1470-2045(21)00279-5 PMID:34270924
271. Rutherford MJ, Arnold M, Bardot A, Ferlay J, De P, Tervonen H, et al. (2021). Comparison of liver cancer incidence and survival by subtypes across seven high-income countries. International Journal of Cancer. 149(12): 2020-2031. https://doi.org/10.1002/ijc.33767 PMID:34460109
272. Ryzhov A, Corbex M, Pineros M, Barchuk A, Andreasyan D, Djanklich S, et al. (2021). Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncology. 22(3): 361-369. https://doi.org/10.1016/S1470-2045(20)30674-4 PMID:33556324
273. Salamat F, Aryannia A, Rajaei S, Naeimi-Tabiei M, Afghani R, Sedaghat SM, et al. (2021). Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013. Archives of Iranian Medicine. 24(1): 1-6. https://doi.org/10.34172/aim.2021.01 PMID:33588561
274. Seraphin TP, Joko-Fru WY, Hammerl L, Griesel M, Mezger NCS, Feuchtner JC, et al. (2021). Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 127(22): 4221-4232. https://doi.org/10.1002/cncr.33818 PMID:34328216
275. Seraphin TP, Joko-Fru WY, Kamate B, Chokunonga E, Wabinga H, Somdyala NIM, et al. (2021). Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network. Cancer Epidemiology, Biomarkers and Prevention. 30(1): 158-165. https://doi.org/10.1158/1055-9965.EPI-20-1005 PMID:33033143
276. Seraphin TP, Joko-Fru WY, Manraj SS, Chokunonga E, Somdyala NIM, Korir A, et al. (2021). Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study. Cancer Causes and Control. 32(9): 1001-1019. https://doi.org/10.1007/s10552-021-01453-x PMID:34244896
277. Snijders R, Fukinsia A, Claeys Y, Hasker E, Mpanya A, Miaka E, et al. (2021). Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo. Emerging Infectious Diseases. 27(8): 2144-2153. https://doi.org/10.3201/eid2708.202399 PMID:34287133
278. Soerjomataram I, Bray F (2021). Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nature Reviews: Clinical Oncology. 18(10): 663-672. https://doi.org/10.1038/s41571-021-00514-z PMID:34079102
279. Soerjomataram I, Ervik M, Fox C, Hawkins S, Yeung K, Napolitano G, et al. (2021). CanStaging+: an electronic staging tool for population-based cancer registries. Lancet Oncology. 22(8): 1069. https://doi.org/10.1016/S1470-2045(21)00188-1 PMID:34339643
280. Stoeter O, Seraphin TP, Chitsike I, Chokunonga E, Kambugu JB, Wabinga H, et al. (2021). Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda). International Journal of Cancer. 149(5): 1002-1012. https://doi.org/10.1002/ijc.33619 PMID:33945631
281. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 71(3): 209-249. https://doi.org/10.3322/caac.21660 PMID:33538338
282. Vaccarella S, Dal Maso L (2021). Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes and Endocrinology. 9(2): 57-59. https://doi.org/10.1016/S2213-8587(20)30426-5 PMID:33347808
283. Vaccarella S, Ginsburg O, Bray F (2021). Gender inequalities in cancer among young adults. Lancet Oncology. 22(2): 166-167. https://doi.org/10.1016/S1470-2045(21)00001-2 PMID:33539738
284. Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schuz J, et al. (2021). Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes and Endocrinology. 9(3): 144-152. https://doi.org/10.1016/S2213-8587(20)30401-0 PMID:33482107
285. Yang Z, Yang J, Li MM, Chen JJ, Ou CQ (2021). Nonlinear and lagged meteorological effects on daily levels of ambient PM2.5 and O-3: Evidence from 284 Chinese cities. Journal of Cleaner Production. 278: 10. https://doi.org/10.1016/j.jclepro.2020.123931
286. Znaor A, Fouad H, Majnoni d’Intignano F, Hammerich A, Slama S, Pourghazian N, et al. (2021). Use of cancer data for cancer control in the Eastern Mediterranean Region: Results of a survey among population-based cancer registries. International Journal of Cancer. 148(3): 593-600. https://doi.org/10.1002/ijc.33223 PMID:32683692
287. Znaor A, Ryzhov A, Corbex M, Pineros M, Bray F (2021). Cervical cancer in the Newly Independent States of the former Soviet Union: Incidence will remain high without action. Cancer Epidemiology. 73: 101944. https://doi.org/10.1016/j.canep.2021.101944 PMID:33975255